Tags

Type your tag names separated by a space and hit enter

Arsenite and its mono- and dimethylated trivalent metabolites enhance the formation of benzo[a]pyrene diol epoxide-DNA adducts in Xeroderma pigmentosum complementation group A cells.
Chem Res Toxicol. 2009 Feb; 22(2):382-90.CR

Abstract

Recently, inorganic arsenite (iAs(III)) and its mono- and dimethylated metabolites have been examined for their interference with the formation and repair of benzo[a]pyrene diol epoxide (BPDE)-induced DNA adducts in human cells (Schwerdtle, ., Walter, I., and Hartwig, A. (2003) DNA Repair 2, 1449 - 1463). iAs(III) and monomethylarsonous acid (MMA(III)) were found to be able to enhance the formation of BPDE-DNA adducts, whereas dimethylarsinous acid (DMA(III)) had no enhancing effect at all. The anomaly manifested by DMA(III) prompted us to further investigate the effects of the three trivalent arsenic species on the formation of BPDE-DNA adducts. Use of a nucleotide excision repair (NER)-deficient Xeroderma pigmentosum complementation group A cell line (GM04312C) allowed us to dissect DNA damage induction from DNA repair and to examine the effects of arsenic on the formation of BPDE-DNA adducts only. At concentrations comparable to those used in the study by Schwerdtle et al., we found that each of the three trivalent arsenic species was able to enhance the formation of BPDE-DNA adducts with the potency in a descending order of MMA(III) > DMA(III) > iAs(III), which correlates well with their cytotoxicities. Similar to iAs(III), DMA(III) modulation of reduced glutathione (GSH) or total glutathione S-transferase (GST) activity could not account for its enhancing effect on DNA adduct formation. Additionally, the enhancing effects elicited by the trivalent arsenic species were demonstrated to be highly time-dependent. Thus, although our study made use of short-term assays with relatively high doses, our data may have meaningful implications for carcinogenesis induced by chronic exposure to arsenic at low doses encountered environmentally.

Authors+Show Affiliations

Department of Laboratory Medicine and Pathology, 10-102 Clinical Sciences Building, University of Alberta, Edmonton, Alberta, Canada.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

19146383

Citation

Shen, Shengwen, et al. "Arsenite and Its Mono- and Dimethylated Trivalent Metabolites Enhance the Formation of Benzo[a]pyrene Diol epoxide-DNA Adducts in Xeroderma Pigmentosum Complementation Group a Cells." Chemical Research in Toxicology, vol. 22, no. 2, 2009, pp. 382-90.
Shen S, Lee J, Cullen WR, et al. Arsenite and its mono- and dimethylated trivalent metabolites enhance the formation of benzo[a]pyrene diol epoxide-DNA adducts in Xeroderma pigmentosum complementation group A cells. Chem Res Toxicol. 2009;22(2):382-90.
Shen, S., Lee, J., Cullen, W. R., Le, X. C., & Weinfeld, M. (2009). Arsenite and its mono- and dimethylated trivalent metabolites enhance the formation of benzo[a]pyrene diol epoxide-DNA adducts in Xeroderma pigmentosum complementation group A cells. Chemical Research in Toxicology, 22(2), 382-90. https://doi.org/10.1021/tx800335p
Shen S, et al. Arsenite and Its Mono- and Dimethylated Trivalent Metabolites Enhance the Formation of Benzo[a]pyrene Diol epoxide-DNA Adducts in Xeroderma Pigmentosum Complementation Group a Cells. Chem Res Toxicol. 2009;22(2):382-90. PubMed PMID: 19146383.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Arsenite and its mono- and dimethylated trivalent metabolites enhance the formation of benzo[a]pyrene diol epoxide-DNA adducts in Xeroderma pigmentosum complementation group A cells. AU - Shen,Shengwen, AU - Lee,Jane, AU - Cullen,William R, AU - Le,X Chris, AU - Weinfeld,Michael, PY - 2009/1/17/entrez PY - 2009/1/17/pubmed PY - 2009/5/9/medline SP - 382 EP - 90 JF - Chemical research in toxicology JO - Chem Res Toxicol VL - 22 IS - 2 N2 - Recently, inorganic arsenite (iAs(III)) and its mono- and dimethylated metabolites have been examined for their interference with the formation and repair of benzo[a]pyrene diol epoxide (BPDE)-induced DNA adducts in human cells (Schwerdtle, ., Walter, I., and Hartwig, A. (2003) DNA Repair 2, 1449 - 1463). iAs(III) and monomethylarsonous acid (MMA(III)) were found to be able to enhance the formation of BPDE-DNA adducts, whereas dimethylarsinous acid (DMA(III)) had no enhancing effect at all. The anomaly manifested by DMA(III) prompted us to further investigate the effects of the three trivalent arsenic species on the formation of BPDE-DNA adducts. Use of a nucleotide excision repair (NER)-deficient Xeroderma pigmentosum complementation group A cell line (GM04312C) allowed us to dissect DNA damage induction from DNA repair and to examine the effects of arsenic on the formation of BPDE-DNA adducts only. At concentrations comparable to those used in the study by Schwerdtle et al., we found that each of the three trivalent arsenic species was able to enhance the formation of BPDE-DNA adducts with the potency in a descending order of MMA(III) > DMA(III) > iAs(III), which correlates well with their cytotoxicities. Similar to iAs(III), DMA(III) modulation of reduced glutathione (GSH) or total glutathione S-transferase (GST) activity could not account for its enhancing effect on DNA adduct formation. Additionally, the enhancing effects elicited by the trivalent arsenic species were demonstrated to be highly time-dependent. Thus, although our study made use of short-term assays with relatively high doses, our data may have meaningful implications for carcinogenesis induced by chronic exposure to arsenic at low doses encountered environmentally. SN - 1520-5010 UR - https://www.unboundmedicine.com/medline/citation/19146383/Arsenite_and_its_mono__and_dimethylated_trivalent_metabolites_enhance_the_formation_of_benzo[a]pyrene_diol_epoxide_DNA_adducts_in_Xeroderma_pigmentosum_complementation_group_A_cells_ DB - PRIME DP - Unbound Medicine ER -